RVMD
Closed
Revolution Medicines Inc
36.89
+0.10 (+0.27%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 36.79
Day's Range: 36.71 - 38.175
Send
sign up or login to leave a comment!
When Written:
20.54
Revolution Medicines Inc. is a clinical-stage precision oncology company that develops targeted therapies for cancer patients. The company was founded in 2014 and is headquartered in Redwood City, California. Revolution Medicines focuses on developing small molecule drugs that target key signaling pathways in cancer cells, including the RAS pathway, which is mutated in approximately 30% of all human cancers.
The company's lead drug candidate, RMC-4630, is a selective inhibitor of SHP2, a protein that plays a critical role in the RAS pathway. The drug is currently being evaluated in clinical trials for the treatment of several types of cancer, including non-small cell lung cancer, colorectal cancer, and solid tumors with RAS mutations.
Revolution Medicines has partnerships with several pharmaceutical companies, including Sanofi and Gilead Sciences, to develop drugs targeting other cancer pathways. The company has raised over $400 million in funding from investors such as Google Ventures, Third Rock Ventures, and Fidelity Investments.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company's lead drug candidate, RMC-4630, is a selective inhibitor of SHP2, a protein that plays a critical role in the RAS pathway. The drug is currently being evaluated in clinical trials for the treatment of several types of cancer, including non-small cell lung cancer, colorectal cancer, and solid tumors with RAS mutations.
Revolution Medicines has partnerships with several pharmaceutical companies, including Sanofi and Gilead Sciences, to develop drugs targeting other cancer pathways. The company has raised over $400 million in funding from investors such as Google Ventures, Third Rock Ventures, and Fidelity Investments.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!